Trial intelligence / Profile preview

HRCT evaluation of airway remodeling after one year of formoterol + budesonide in moderate asthma

ChiCTR-TNRC-09000437Phase 4Completed

Sponsor
West China Hospital of Sichuan University
Start
Jun 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of formoterol and budesonide in asthma (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: HRCT scale. Started Jun 2007; status: completed.

02

Drugs

formoterolbudesonide
03

Conditions

asthma

Beyond the preview

Go deeper on ChiCTR-TNRC-09000437.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TNRC-09000437.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call